Free Trial

Procter & Gamble Company (The) $PG Shares Sold by CORDA Investment Management LLC.

Procter & Gamble logo with Consumer Staples background

Key Points

  • CORDA Investment Management LLC reduced its position in Procter & Gamble by 2.1%, now holding 226,733 shares valued at approximately $36.1 million, making it their 13th largest holding.
  • Procter & Gamble's stock is currently trading at $151.53 with a market capitalization of $354.66 billion and reported Q1 earnings per share of $1.48, exceeding estimates.
  • The company has announced a quarterly dividend of $1.0568, which is set to be paid on November 17th, yielding about 2.8% annually, with an ex-dividend date of October 24th.
  • MarketBeat previews top five stocks to own in November.

CORDA Investment Management LLC. decreased its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 226,733 shares of the company's stock after selling 4,974 shares during the period. Procter & Gamble accounts for approximately 2.7% of CORDA Investment Management LLC.'s portfolio, making the stock its 13th biggest holding. CORDA Investment Management LLC.'s holdings in Procter & Gamble were worth $36,123,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC increased its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC acquired a new position in Procter & Gamble during the first quarter worth approximately $1,954,941,000. Price T Rowe Associates Inc. MD increased its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. increased its holdings in shares of Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC increased its holdings in shares of Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Stock Up 1.3%

Procter & Gamble stock opened at $151.53 on Monday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a 1-year low of $146.96 and a 1-year high of $180.43. The company has a market cap of $354.66 billion, a PE ratio of 23.28, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The stock's 50 day moving average price is $154.92 and its 200 day moving average price is $158.67.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble's payout ratio is presently 64.98%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 490 shares of the business's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider directly owned 12,616 shares in the company, valued at approximately $1,920,533.68. The trade was a 3.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jon R. Moeller sold 11,684 shares of the business's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $1,778,655.32. Following the sale, the chief executive officer owned 319,932 shares in the company, valued at approximately $48,703,248.36. The trade was a 3.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock valued at $23,421,279 in the last 90 days. 0.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. JPMorgan Chase & Co. dropped their target price on Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating on the stock in a report on Friday, October 10th. Weiss Ratings reissued a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Bank of America dropped their target price on Procter & Gamble from $180.00 to $174.00 and set a "buy" rating on the stock in a report on Wednesday, October 8th. Barclays dropped their target price on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Finally, BNP Paribas Exane dropped their target price on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and an average target price of $172.21.

Read Our Latest Stock Report on PG

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.